Targeting sg-RSPO3#1 and sg-RSPO3#2 led to a notable decrease in RSPO3 promoter DNA methylation in CCA cells QBC939 and HCCC9810 (Fig. 4G). This evidence concerns the gene RSPO3 and cholangiocarcinoma.